Snowball logo
logo
KVUE

Kenvue Inc.

$19.205+$0.225Β  (1.19%)
KVUE's financial landscape has seen some notable s...
View AAPL example
Estimate
P/E
22.6
EPS
0.85
Beta
0.431
Growth
Revenue, YoY
3.02%
Net income, YoY
8.57%
FCF, YoY
55.12%
Forecast
P/E (FWD)
15.5
EPS (FWD)
1.242
Dividends
Dividend yield
4.37%
Annual payout
$0.84
Next ex. div date
August 12, 26
Payout
143.37%
Dividend growth streak
2 y
Div.rating
About the company
Ticker
KVUE
ISIN
US49177J1025
Country
United States of America
Sector (GICS)
Consumer Staples
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.

Frequently asked questions

What sector does Kenvue Inc. (KVUE) operate in?

Kenvue Inc. belongs to the Consumer Staples sector and operates in the Household & Personal Products industry.

What is Kenvue Inc. (KVUE) current stock price?

As of the latest data, Kenvue Inc. stock price is $19.21, with a previous close of $18.98. Kenvue Inc. gained $0.23 in the last trading session, representing a 1.19% increase.

What is Kenvue Inc. (KVUE) current market capitalization?

Kenvue Inc. market cap is approximately 36.87 billion.

What is Kenvue Inc. (KVUE) Earnings Per Share (EPS)?

The trailing EPS is $0.85, and the forward EPS is $1.24.

What is Kenvue Inc. (KVUE) Price-to-Earnings (P/E) ratio?

Kenvue Inc. current P/E ratio is 22.59, with a forward P/E of 15.46.

What is Kenvue Inc. (KVUE) EBITDA?

Kenvue Inc. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 833.00 million.

Does Kenvue Inc. (KVUE) pay dividends?

Yes. Kenvue Inc. pays quarterly dividends with an annualized yield of 4.37% and an estimated annual payout of $0.84 per share.

When is the next ex-dividend date for Kenvue Inc. (KVUE)?

The next ex-dividend date is scheduled for August 12, 2026.

How did Kenvue Inc. (KVUE) perform in its most recent earnings report?

In the last report (June 30, 2026), Kenvue Inc. posted an EPS surprise of -3.13% and a revenue surprise of -0.36%.

What is Kenvue Inc. (KVUE) beta (volatility) score?

Kenvue Inc. has a beta of 0.431, indicating lower volatility than the overall market.